Christopher Klein
Overview
Christopher Klein received an average of $1M in total compensation, including $404K in salary, at RVL Pharmaceuticals plc from 2019 to 2022.
Source: SEC filings on April 24, 2023, April 25, 2022, April 26, 2021, and April 20, 2020.
Related executives
We found four more executives who work or worked at RVL Pharmaceuticals plc.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020